In vivo CAR T-cell therapy could revolutionize cancer treatment by bypassing traditional manufacturing, reducing costs, and minimizing adverse events. Kelonia Therapeutics' KLN-1010 has shown ...

Linda Hezel gets up early to clip herbs, vegetables and produce from the plants on her farm north of Kansas City. “I'm trying peppers which you normally think would be only in full sun,” Hezel said.

The first time Chris Dahl heard rumblings of a plan to build a large solar array among the corn fields and tobacco sheds of East Windsor, she said the project sounded like a good enough idea. A ...

Snoop Dogg and Eli Roth are on board to produce the Media Capital Technologies and Horror Section horror pic Don’t Go In That House, Bitch!, with Roth also directing and the rap icon also writing and ...

The selloff in Array Digital Infrastructure's fixed-income securities post-UScellular sale is overdone, creating an attractive entry point. AD's 5.50% Senior Notes now yield 8.05% and trade at a 31.6% ...

Millions of AT&T customers can now file claims in a $177 million legal settlement related to two data breaches, which could provide up to $7,500 in compensation per person. Multiple lawsuits were ...

Millions of AT&T customers can file claims worth up to $7,500 in cash payments as part of a $177 million settlement related to data breaches in 2024. The telecommunications company had faced a pair of ...

After suffering two significant data breaches in recent years, AT&T has agreed to pay $177 million to customers affected by the incidents. Some individuals could receive as much as $5,000 as part of ...

BELLEVUE, Wash.--(BUSINESS WIRE)--T-Mobile US, Inc. (NASDAQ: TMUS) (the “Company”) today announced, together with T-Mobile USA, Inc., its wholly-owned subsidiary (“T-Mobile USA”), the expiration and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Chicago-based wireless company ...

AbbVie is making a full strength play for the in vivo CAR-T market, snapping up Capstan Therapeutics for $2.1 billion to add an early-phase autoimmune drug candidate to its pipeline. Capstan is part ...